Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 30,185 | 26,299 | 20,988 | 20,910 | 24,209 |
| Cost of Goods | 6,222 | 6,053 | 4,912 | 5,343 | 5,951 |
| Gross Profit | 23,963 | 20,246 | 16,076 | 15,567 | 18,258 |
| Operating Expenses | 68,424 | 57,348 | 53,897 | 50,530 | 43,397 |
| Operating Income | -44,239 | -37,049 | -36,909 | -34,620 | -24,188 |
| Other Income | 785 | 1,018 | 1,893 | 2,894 | 3,577 |
| Pre-tax Income | -43,454 | -36,031 | -35,016 | -31,726 | -20,611 |
| Income Tax | N/A | 688 | -1,481 | -323 | N/A |
| Net Income Continuous | -44,570 | -36,719 | -33,535 | -31,403 | -20,611 |
| Net Income | $-44,570 | $-36,719 | $-33,535 | $-31,403 | $-20,611 |
| EPS Basic Total Ops | -0.33 | -0.27 | -0.26 | -0.25 | 1.78 |
| EPS Basic Continuous Ops | -0.33 | -0.27 | -0.26 | -0.25 | 1.73 |
| EPS Diluted Total Ops | -0.33 | -0.27 | -0.26 | -0.25 | 1.78 |
| EPS Diluted Continuous Ops | -0.33 | -0.27 | -0.26 | -0.25 | 1.73 |
| EBITDA(a) | $-40,630 | $-34,738 | $-35,006 | $-33,198 | $-23,043 |